<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="./PMC6339437/results/search/disease/results.xml">
  <result pre="novel herbal formula made from the five plants (C2RLP) against" exact="atopic dermatitis" post="in BALB/C mice. Methods Mice were allocated into five"/>
  <result pre="herbal formula made from the five plants (C2RLP) against atopic" exact="dermatitis" post="in BALB/C mice. Methods Mice were allocated into five"/>
  <result pre="Liquid Chromatography-Mass Spectrometry. Results Topical application of C2RLP reduced the" exact="dermatitis" post="score and suppressed histopathological changes in mice. Treatment significantly"/>
  <result pre="3-glucoside. Conclusion Down-regulation of T- helper 2 cellular responses and" exact="suppression" post="of inflammatory mediators contributed to the protective effects of"/>
  <result pre="inflammatory mediators contributed to the protective effects of C2RLP from" exact="atopic dermatitis" post="in BALB/C mice. Keywords Atopic dermatitis Inflammation Mice Skin"/>
  <result pre="mediators contributed to the protective effects of C2RLP from atopic" exact="dermatitis" post="in BALB/C mice. Keywords Atopic dermatitis Inflammation Mice Skin"/>
  <result pre="of C2RLP from atopic dermatitis in BALB/C mice. Keywords Atopic" exact="dermatitis" post="Inflammation Mice Skin Funding Forest Resources Development Institute and"/>
  <result pre="Agriculture, Science and Technology, Korea PJ01128901 Park Seung-Chun Background Atopic" exact="dermatitis" post="(AD) is an allergic skin disease characterized by complex"/>
  <result pre="thymus and activation-regulated chemokine (TARC) recruits Th2-lymphocytes and further aggravate" exact="dermatitis" post="[ 7]. Authors also suggested that the release of"/>
  <result pre="main complaints of the disease such as pruritus, dryness, and" exact="psoriasis" post="on the skin [ 24]. Therefore, the study was"/>
  <result pre="neutral buffered formalin. Fig. 1 Experimental schedule for induction of" exact="atopic dermatitis" post="and treatment with C2RLP in BALB/C mice Evaluation of"/>
  <result pre="buffered formalin. Fig. 1 Experimental schedule for induction of atopic" exact="dermatitis" post="and treatment with C2RLP in BALB/C mice Evaluation of"/>
  <result pre="skin lesion Skin lesions were recorded for each animal and" exact="dermatitis" post="were scored once every five days, as follows ["/>
  <result pre="of the treatment and control groups conducted the evaluation of" exact="dermatitis" post="score. Histopathological investigation Paraffin-embedded specimens were sectioned to 5 μm"/>
  <result pre="accordance with the findings in the NO assay, a significant" exact="suppression" post="of iNOS gene expression was observed following treatment with"/>
  <result pre="on AD-like skin lesions in mice Cutaneous findings related to" exact="atopic dermatitis" post="such as mild to moderate erythema, skin dryness, edema,"/>
  <result pre="AD-like skin lesions in mice Cutaneous findings related to atopic" exact="dermatitis" post="such as mild to moderate erythema, skin dryness, edema,"/>
  <result pre="following application of DNCB for almost 2 weeks (with an average" exact="dermatitis" post="score of 6.8) in the petrolatum treated control mice."/>
  <result pre="of treatment, respectively. However, a slight degree of erythema and" exact="alopecia" post="were evident in the 2.5% C2RLP treated group. At"/>
  <result pre="C2RLP treated group. At the end of treatment, the average" exact="dermatitis" post="score of the 2.5, 5% C2RLP and betamethasone treated"/>
  <result pre="e, f). These findings were 2–3 folds lower than the" exact="dermatitis" post="score recorded for the petrolatum treated control mice. Therefore,"/>
  <result pre="cytokines, and chemokines that are essential in the progression of" exact="dermatitis" post="[ 36]. Our study showed that C2RLP treatment suppressed"/>
  <result pre="The Th1/Th2 cytokine imbalance is vital in the progression of" exact="atopic dermatitis," post="with increased production of IgE and mast cell activation"/>
  <result pre="conditions that resembles AD such as eczema [ 50] and" exact="alopecia" post="areata [ 51]. Therefore, the antioxidant activity of C2RLP"/>
  <result pre="acid, and Kaempferol 3-glucoside (Table 1). Previous studies indicated that" exact="suppression" post="of NF-κB and MAP- kinases (mitogen-activated protein kinases) are"/>
  <result pre="protective effect of C2RLP in the development of AD. Therefore," exact="suppression" post="of AD-like lesions in C2RLP treated mice might be"/>
  <result pre="vivo toxic effects of C2RLP. C2RLP attenuates the symptoms of" exact="atopic dermatitis" post="in mice by modifying local and systemic inflammation. It"/>
  <result pre="toxic effects of C2RLP. C2RLP attenuates the symptoms of atopic" exact="dermatitis" post="in mice by modifying local and systemic inflammation. It"/>
  <result pre="local and systemic inflammation. It produces a marked reduction in" exact="dermatitis" post="score and inflammatory cell infiltration; and decreased the production"/>
  <result pre="molecular mechanism (s) of C2RLP are needed. Abbreviations AD Atopic" exact="dermatitis" post="DNCB 1-Chloro-2, 4-dinitrobenzene HE Hematoxylin-Eosin IFN-γ Interferon- γ IgE"/>
  <result pre="institutional affiliations. References References 1. Rudikoff D Lebwohl M Atopic" exact="dermatitis" post="Lancet 1998 351 1715 1721 10.1016/S0140-6736(97)12082-7 9734903 2. Leung"/>
  <result pre="FC Mudde GC et al. Biphasic response against aeroallergen in" exact="atopic dermatitis" post="showing a switch from an initial T(H2) response to"/>
  <result pre="Mudde GC et al. Biphasic response against aeroallergen in atopic" exact="dermatitis" post="showing a switch from an initial T(H2) response to"/>
  <result pre="TARC, produced by keratinocytes may recruit CLA+CCR4+ lymphocytes into lesional" exact="atopic dermatitis" post="skin J Invest Dermatol 2000 115 4 640 646"/>
  <result pre="produced by keratinocytes may recruit CLA+CCR4+ lymphocytes into lesional atopic" exact="dermatitis" post="skin J Invest Dermatol 2000 115 4 640 646"/>
  <result pre="Nasal mucosal expression of nitric oxide synthases in patients with" exact="allergic rhinitis" post="and its relation to asthma Ann Allergy Asthma Immunol"/>
  <result pre="mucosal expression of nitric oxide synthases in patients with allergic" exact="rhinitis" post="and its relation to asthma Ann Allergy Asthma Immunol"/>
  <result pre="synthases in patients with allergic rhinitis and its relation to" exact="asthma" post="Ann Allergy Asthma Immunol 2007 100 1 12 16"/>
  <result pre="M Ruzicka T Healy E et al. Proactive treatment of" exact="atopic dermatitis" post="in adults with 0.1% tacrolimus ointment Allergy Eur J"/>
  <result pre="Ruzicka T Healy E et al. Proactive treatment of atopic" exact="dermatitis" post="in adults with 0.1% tacrolimus ointment Allergy Eur J"/>
  <result pre="Sánchez-Ramón S Suárez Fernández R Omalizumab for the treatment of" exact="atopic dermatitis" post="Actas Dermosifiliogr 2012 103 7 624 628 10.1016/j.ad.2011.07.013 22056257"/>
  <result pre="S Suárez Fernández R Omalizumab for the treatment of atopic" exact="dermatitis" post="Actas Dermosifiliogr 2012 103 7 624 628 10.1016/j.ad.2011.07.013 22056257"/>
  <result pre="M-Y Shin H-K Morus alba L. suppresses the development of" exact="atopic dermatitis" post="induced by the house dust mite in NC/Nga mice"/>
  <result pre="Shin H-K Morus alba L. suppresses the development of atopic" exact="dermatitis" post="induced by the house dust mite in NC/Nga mice"/>
  <result pre="effect of diet supplemented with rice prolamin extract against DNCB-induced" exact="atopic dermatitis" post="in BALB/c mice. BMC Complement Altern Med. 2015;15:353. 33."/>
  <result pre="of diet supplemented with rice prolamin extract against DNCB-induced atopic" exact="dermatitis" post="in BALB/c mice. BMC Complement Altern Med. 2015;15:353. 33."/>
  <result pre="Lim SC Kim SC Choi HK Kang KW Inhibition of" exact="dermatitis" post="development by sopungsan in NC/NGA mice Toxicol Res 2008"/>
  <result pre="Inagaki N Nagai H Kampo medicines for mite antigen-induced allergic" exact="dermatitis" post="in NC/Nga mice Evidence-based Complement Altern Med. 2005 2"/>
  <result pre="inhibition of nitric oxide synthase gene expression by curcumin, a" exact="cancer" post="preventive natural product with anti-inflammatory properties Biochem Pharmacol 1998"/>
  <result pre="K The NC / Nga mouse : a model for" exact="atopic dermatitis" post="Mol Med Today 2000 6 209 210 10.1016/S1357-4310(00)01683-X 10782068"/>
  <result pre="The NC / Nga mouse : a model for atopic" exact="dermatitis" post="Mol Med Today 2000 6 209 210 10.1016/S1357-4310(00)01683-X 10782068"/>
  <result pre="MDC/CCL22, and Mig/CXCL9) are elevated in sera from patients with" exact="atopic dermatitis" post="J Dermatol Sci 2004 34 3 201 208 10.1016/j.jdermsci.2004.01.001"/>
  <result pre="and Mig/CXCL9) are elevated in sera from patients with atopic" exact="dermatitis" post="J Dermatol Sci 2004 34 3 201 208 10.1016/j.jdermsci.2004.01.001"/>
  <result pre="of panduratin a on allergy-related mediator production in rat basophilic" exact="leukemia" post="mast cells Inflammation 2012 35 6 1904 1915 10.1007/s10753-012-9513-y"/>
  <result pre="Rajeev G Role of reactive oxygen species and antioxidants in" exact="atopic dermatitis" post="J Clin Diagnostic Res 2013 7 12 2683 2685"/>
  <result pre="G Role of reactive oxygen species and antioxidants in atopic" exact="dermatitis" post="J Clin Diagnostic Res 2013 7 12 2683 2685"/>
  <result pre="and altered antioxidant defenses in children with acute exacerbation of" exact="atopic dermatitis" post="Life Sci 2003 72 22 2509 2516 10.1016/S0024-3205(03)00145-0 12650859"/>
  <result pre="altered antioxidant defenses in children with acute exacerbation of atopic" exact="dermatitis" post="Life Sci 2003 72 22 2509 2516 10.1016/S0024-3205(03)00145-0 12650859"/>
  <result pre="10.1016/S0024-3205(03)00145-0 12650859 48. Ji H Li XK Oxidative stress in" exact="atopic dermatitis" post="Oxidative Med Cell Longev 2016 7 1 8 10.1155/2016/2721469"/>
  <result pre="12650859 48. Ji H Li XK Oxidative stress in atopic" exact="dermatitis" post="Oxidative Med Cell Longev 2016 7 1 8 10.1155/2016/2721469"/>
  <result pre="OA Elshazly RMA Shoeib MAM Gooda A Oxidative stress in" exact="alopecia" post="areata: a case-control study Am J Clin Dermatol 2014"/>
  <result pre="tacrolimus 0.1% ointments versus tacrolimus alone in the treatment of" exact="atopic dermatitis" post="Cutis 2006 78 5 357 363 17186796 53. Kwon"/>
  <result pre="0.1% ointments versus tacrolimus alone in the treatment of atopic" exact="dermatitis" post="Cutis 2006 78 5 357 363 17186796 53. Kwon"/>
  <result pre="SB Kim DG Shin JY et al. Loganin protects against" exact="pancreatitis" post="by inhibiting NF-κB activation Eur J Pharmacol 2015 765"/>
 </snippets>
</snippetsTree>
